Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 15 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 6,210 followers.

RT @FrontPharmacol: New Research: Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular…

25 Nov 2022

Reply Repost Favourite

RT @AhmedFathelrah2: The 5th paper I handled as a guest editor for Frontiers in Pharmacology under the research topic collection "Medicatio…

24 Nov 2022

Reply Repost Favourite

New Research: Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents https://t.co/2rwr3x2vtN #pharmacology

16 Nov 2022

Reply Repost Favourite

The 5th paper I handled as a guest editor for Frontiers in Pharmacology under the research topic collection "Medication Safety and Interventions to Reduce Patient Harm in Low - and Middle-Income Countries. Wishing you pleasant read: https://t.co/t1bR8JIVZ

16 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.